About Us

      Provectus Algae is an Australian biotech startup specialising in the optimisation of Algae to produce high-value compounds for use in a wide array of industries and applications. 
      The groundbreaking capabilities of the Provectus Algae team are enabled by a well-balanced fusion of its proprietary innovative technology and a thorough understanding of the unique biological traits of algae.


      Executive Team


      Nusqe Spanton

      Founder & CEO

      Algae and Aquaculture expert with 15 years experience in international aquaculture production, corporate management and marine biotechnology applications for public and private companies. Passionate and motivated leader with a proven track record in complex project delivery.


      Mic Black

      Founder & CTO

      Lighting and IoT specialist with 17 years experience in rapid prototyping for startups and research organisations. Senior
      electronics engineering and edge computing architecture specialist. Well regarded in the Australian tech and startup scene as a prolific inventor and multi-award winning technologist.

      Board & Advisers


      David Williams

      Chairman, Board of Directors

      Corporate, merger and acquisitions specialist and commercial lawyer for 35+ years


      Tom Himstedt

      Non-Executive Director

      Tom is an operational executive with more than 20 years’ experience in vertically integrated food manufacturing, commercial product development and nutraceutical R&D. 


      Roslyn Hendriks

      Adviser Biotechnology & Commercialisation

      Raised $40M in high risk capital. Brought medical innovations to market. Former General Manager UniQuest commercialising research.


      Garry Redlich

      Adviser Biotechnology & Technical Scale-up

      Successfully brought 2 drugs to advanced clinical development and 1 to global regulatory approval. Federal government level advisor.


      Kevin Grant

      Adviser Regulatory Requirements

      35 years principal biochemist at Therapeutic Goods Administration (TGA)

      Why Algae

      High-value algae strains are heralded as the eco super-crop of the future but they have typically been difficult to grow in commercial quantities- until now.
      We have the technology to capitalise on an existing market, mature it and be a driving force in the future of bioceuticals and aquaculture.


      Our goals are ambitious and we look forward to significant projected growth over the next couple of years. Our team is agile, lean, skilled and driven. As seasoned entrepreneurs, we like to keep it light in the workplace even when there’s a lot to be done and look forward to building a team who are ready to come on a journey with us to make a significant impact.

      • Illustration
        Synthetic Biology and Bioprocessing Manager 
         $ TBA
          Noosaville, Australia
          3 years experience

        We’re looking for an exceptional scientist with a commercial attitude to join the senior team and spearhead the commercialisation of biologics from algae. You will manage the design and build of the up stream (USP) and downstream processing (DSP) facility and have the skills and imagination to carry out high efficiency genetic engineering on algae. 

      Didn't find a suitable vacancy but want to reach out anyway? Feel free to contact us.